TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Strängnäsvaccin AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,441
|
3,501
|
3,333 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
143
|
-221
|
-362 |
| EBITDA |
160
|
-82
|
-219 |
| Total assets |
1,178
|
1,243
|
1,587 |
| Current assets |
1,053
|
1,090
|
1,300 |
| Current liabilities |
106
|
97
|
133 |
| Equity capital |
1,061
|
1,142
|
1,448 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
3
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.1%
|
91.9%
|
91.2% |
| Turnover per employee | 1,480 | ||
| Profit as a percentage of turnover |
3.2%
|
-6.3%
|
-10.9% |
| Return on assets (ROA) |
12.1%
|
-17.8%
|
-22.7% |
| Current ratio |
993.4%
|
1123.7%
|
977.4% |
| Return on equity (ROE) |
13.5%
|
-19.4%
|
-25.0% |
| Change turnover |
877
|
-69
|
-254 |
| Change turnover % |
25%
|
-2%
|
-7% |
| Chg. No. of employees |
3
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.